IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Annals of Cancer Research and Therapy

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

0.29

h-Index

2024-2025

 7

Rank

2024-2025

 21466

SJR

2024-2025

 0.195

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Annals of Cancer Research and Therapy
Abbreviation Ann. Cancer Res. Ther.
Publication Type Journal
Subject Area, Categories, Scope Cancer Research (Q4); Oncology (Q4); Pharmacology (medical) (Q4)
h-index 7
Overall Rank/Ranking 21466
SCImago Journal Rank (SJR) 0.195
Impact Score 0.29
Publisher PJD Publications Ltd
Country United States
ISSN 13446835
Best Quartile Q4
Coverage History 1992-1998, 2000, 2002-2024




About Annals of Cancer Research and Therapy


Annals of Cancer Research and Therapy is a journal covering the technologies/fields/categories related to Cancer Research (Q4); Oncology (Q4); Pharmacology (medical) (Q4). It is published by PJD Publications Ltd. The overall rank of Annals of Cancer Research and Therapy is 21466. According to SCImago Journal Rank (SJR), this journal is ranked 0.195. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 7. The best quartile for this journal is Q4.

The ISSN of Annals of Cancer Research and Therapy journal is 13446835. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Annals of Cancer Research and Therapy is cited by a total of 20 articles during the last 3 years (Preceding 2024).


Annals of Cancer Research and Therapy Impact IF 2024-2025


The Impact IF 2024 of Annals of Cancer Research and Therapy is 0.29, which is computed in 2025 as per its definition. Annals of Cancer Research and Therapy IF is decreased by a factor of 0.12 and approximate percentage change is -29.27% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Annals of Cancer Research and Therapy Impact IF 2025 Prediction


Impact IF 2024 of Annals of Cancer Research and Therapy is 0.29. If the same downward trend persists, Impact IF may fall in 2025 as well.


Impact IF Trend


Year wise Impact IF of Annals of Cancer Research and Therapy. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 0.29
2023 0.41
2022 0.28
2021 0.20
2020 0.08
2019 0.10
2018 0.18
2017 0.21
2016 0.14
2015 0.25
2014 0.11

Annals of Cancer Research and Therapy h-index


  Table Setting

Annals of Cancer Research and Therapy has an h-index of 7. It means 7 articles of this journal have more than 7 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Annals of Cancer Research and Therapy ISSN


The ISSN of Annals of Cancer Research and Therapy is 13446835. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Annals of Cancer Research and Therapy Rank and SCImago Journal Rank (SJR)


The overall rank of Annals of Cancer Research and Therapy is 21466. According to SCImago Journal Rank (SJR), this journal is ranked 0.195. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Annals of Cancer Research and Therapy by Year


Year SJR
2025/2026 Coming Soon
2024 0.195
2023 0.192
2022 0.135
2021 0.140
2020 0.110
2019 0.128
2018 0.165
2017 0.148
2016 0.103
2015 0.105
2014 0.126

Ranking of Annals of Cancer Research and Therapy by Year


Year Ranking
2025/2026 Coming Soon
2024 21466
2023 20367
2022 22948
2021 21719
2020 28604
2019 23659
2018 20108
2017 21209
2016 28952
2015 27851
2014 23254

Annals of Cancer Research and Therapy Publisher


Table Setting

Annals of Cancer Research and Therapy is published by PJD Publications Ltd. It's publishing house is located in United States. Coverage history of this journal is as following: 1992-1998, 2000, 2002-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Annals of Cancer Research and Therapy is Ann. Cancer Res. Ther.. This abbreviation ('Ann. Cancer Res. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Annals of Cancer Research and Therapy


If your research field is/are related to Cancer Research (Q4); Oncology (Q4); Pharmacology (medical) (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Annals of Cancer Research and Therapy?

Annals of Cancer Research and Therapy latest impact IF is 0.29. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 0.41 (2023) and 0.08 (2020), respectively, in the last 11 years. Moreover, its average IS is 0.2 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Annals of Cancer Research and Therapy?

The Annals of Cancer Research and Therapy has an SJR (SCImago Journal Rank) of 0.195, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.195 in 2024 and the lowest being 0.103 in 2016. Furthermore, the average SJR of the Annals of Cancer Research and Therapy over the previous 11-year period stands at 0.2.


What's the latest h-index of the Annals of Cancer Research and Therapy?

The latest h-index of the Annals of Cancer Research and Therapy is 7.


Who's the publisher of the Annals of Cancer Research and Therapy?

The Annals of Cancer Research and Therapy is published by the PJD Publications Ltd, with its country of publication being the United States.


What's the current ranking of the Annals of Cancer Research and Therapy?

The Annals of Cancer Research and Therapy is currently ranked 21466 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 20108 in 2018 and its lowest position of 28952 in 2016.


What's the abbreviation or short name for the Annals of Cancer Research and Therapy?

The standard ISO4 abbreviation for the Annals of Cancer Research and Therapy is Ann. Cancer Res. Ther..


Is the "Annals of Cancer Research and Therapy" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Annals of Cancer Research and Therapy is classified as a journal that the PJD Publications Ltd publishes.


What's the scope or major areas of the Annals of Cancer Research and Therapy?

The Annals of Cancer Research and Therapy encompasses the following areas:

  • Cancer Research
  • Oncology
  • Pharmacology (medical)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Annals of Cancer Research and Therapy?

The Annals of Cancer Research and Therapy is assigned the following International Standard Serial Numbers (ISSN): 13446835.


What's the best quartile of the Annals of Cancer Research and Therapy?

The best quartile for the Annals of Cancer Research and Therapy is Q4 (2024).


What's the coverage history of the Annals of Cancer Research and Therapy?

The Annals of Cancer Research and Therapy coverage history can be summarized as follows: 1992-1998, 2000, 2002-2024.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Business: Theory and Practice journal 16073 Vilnius Gediminas Technical University 31 2.45
Journal of Field Archaeology journal 7683 Maney Publishing 48 1.85
Journal of Geriatric Physical Therapy journal 8686 Lippincott Williams and Wilkins Ltd. 53 1.55
IEEE/OSA Journal of Display Technology journal 12809 IEEE Computer Society 68 0.00
Journal of Competition Law and Economics journal 11978 Oxford University Press 34 0.94
Istanbul University - Journal of Electrical and Electronics Engineering journal 24654 University of Istanbul 0 0.00
Air and Space Power Journal (discontinued) journal 28397 AU Press 9 0.20
Libyan Studies journal 21508 Cambridge University Press 10 0.14
Archives of the Balkan Medical Union journal 26504 Balkan Medical Union 13 0.20
Biological Procedures Online journal 5232 BioMed Central Ltd 51 4.00

Check complete list




Year wise Impact Score (IS) of Annals of Cancer Research and Therapy

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 0.29
2023 0.41
2022 0.28
2021 0.20
2020 0.08
2019 0.10
2018 0.18
2017 0.21
2016 0.14
2015 0.25
2014 0.11



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Neuro-Oncology
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
John Wiley and Sons Inc | United States

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Annals of Oncology
Elsevier Ltd | United Kingdom

Cancer Cell
Cell Press | United States

Nature Cancer
Nature Research | United States

Lancet Oncology, The
Elsevier Ltd | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Drugs
| Switzerland

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Alimentary Pharmacology and Therapeutics
John Wiley and Sons Inc | United Kingdom

American Journal of Transplantation
Elsevier B.V. | Netherlands

Acta Pharmacologica Sinica
Springer Nature | United Kingdom

BioDrugs
| Switzerland

npj Vaccines
Nature Publishing Group | United Kingdom

See All